Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,095 | 81,444 | 80,620 | 14,769 | N/A |
| Receivables | 94 | 825 | 6,782 | N/A | N/A |
| Inventories | 106 | 106 | 69 | N/A | N/A |
| TOTAL | $77,284 | $83,372 | $88,523 | $15,024 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,523 | 1,439 | 799 | 793 | N/A |
| Intangibles | 0 | 0 | 0 | 22 | 0 |
| Other Non-Current Assets | 348 | 231 | 0 | 1,471 | 0 |
| TOTAL | $1,871 | $1,670 | $799 | $2,286 | $N/A |
| Total Assets | $79,155 | $85,042 | $89,322 | $17,310 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,193 | 1,178 | 1,098 | 461 | 0 |
| Accrued Expenses | 1,417 | 2,043 | 1,734 | 1,788 | N/A |
| TOTAL | $3,948 | $4,559 | $4,169 | $2,249 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,338 | 1,338 | 1,337 | N/A | N/A |
| TOTAL | $4,628 | $4,963 | $5,298 | $N/A | $N/A |
| Total Liabilities | $8,576 | $9,522 | $9,467 | $2,249 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18 | 18 | 18 | N/A | N/A |
| Common Shares | 25 | 25 | 25 | 8 | N/A |
| Retained earnings | -150,548 | -145,422 | -140,903 | -151,752 | N/A |
| Other shareholders' equity | -2,886 | -3,071 | -3,255 | 161,787 | 0 |
| TOTAL | $70,579 | $75,520 | $79,855 | $15,061 | $N/A |
| Total Liabilities And Equity | $79,155 | $85,042 | $89,322 | $17,310 | $0 |